Bryn Mawr Trust CO Guardant Health, Inc. Transaction History
Bryn Mawr Trust CO
- $5.51 Billion
- Q2 2025
A detailed history of Bryn Mawr Trust CO transactions in Guardant Health, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 66 shares of GH stock, worth $3,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66
Previous 66
-0.0%
Holding current value
$3,579
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GH
# of Institutions
403Shares Held
123MCall Options Held
1.43MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.1MShares$655 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$609 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$295 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$279 Million0.04% of portfolio
-
Baillie Gifford & CO4.81MShares$261 Million0.2% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.54B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...